Dove Pharma LLP
About Dove Pharma LLP
Data last updated:
Dove Pharma LLP is a limited liability partnership (LLP) based in Mumbai, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 10 May 2012 and has been in existence for over 14 years.
The LLP is registered with the Registrar of Companies (ROC), Mumbai, under LLPIN AAA-9155. Its GSTIN is 27AAIFD7037J1Z7 (Maharashtra).
The LLP has a total obligation of contribution of ₹5 Lakh. It is led by designated partners including Sanjay Mukutlal Gupta and Rajendrakumar Makhanlal Gupta.
Its latest statement of accounts is for the year ended 31 March 2025. The registered office is at 601 Lotus Business Park, Mumbai, Maharashtra.
As per the financials filed for FY 2021, the LLP reported a revenue of ₹8.35 Cr, a growth of 31% compared to the previous year. For the same year it recorded a net profit of ₹60.79 Lakh (net margin 7.3%) and EBITDA of ₹75.66 Lakh (EBITDA margin 9.1%). Revenue has grown at a compounded annual rate (CAGR) of 50% over three years and 49% over five years.
As per MCA filings, the LLP has open charges of ₹1 Cr on record.
Company details
Contact details
Dove Pharma LLP's registered office is in Mumbai, Maharashtra. Its e-mail address is in the company report.
- Email
- Registered Address601 Lotus Business Park Premises Chs Ltd, Ram Baug Lane Off Sv Road Opp. Malad Dalmil Compound, Mumbai, Maharashtra, India – 400064
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Dove Pharma LLP, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Dove Pharma LLP
FY 2025 filings availableDove Pharma LLP reported revenue of ₹8.35 Cr (up 31% YoY) for FY 2021.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 49% over five years, including 31% growth in the latest year. EBITDA rose 48% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Statement of Account and Solvency | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 | FY 2016-17 |
|---|---|---|---|---|---|
| Income and Expenditure | |||||
| Turnover | |||||
| Other Income | |||||
| Total Income | ₹8.35 Cr | ||||
| Purchases and Direct Costs | |||||
| Personnel Expenses | |||||
| Administrative Expenses | |||||
| Interest | |||||
| Depreciation | |||||
| Total Expenses | |||||
| Profit Before Tax | |||||
| Tax | |||||
| Profit After Tax | ₹60.79 Lakh | ||||
| Profit Transferred to Partners | |||||
| Assets and Liabilities | |||||
| Partners' Contribution | |||||
| Reserves and Surplus | |||||
| Secured Loans | |||||
| Unsecured Loans | |||||
| Trade Payables | |||||
| Other Liabilities and Provisions | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Loans and Advances | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Statement of Account and Solvency | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 | FY 2016-17 |
|---|---|---|---|---|---|
| Profitability | |||||
| Net Profit Margin | 7.3% | ||||
| Return on Partners' Funds | |||||
| Return on Assets | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Debt to Partners' Funds | |||||
| Interest Coverage | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Turnover Growth | |||||
| Profit Growth | |||||
To see the full financial statements and ratios of Dove Pharma LLP, buy the company report.
Designated partners of Dove Pharma LLP
Dove Pharma has 3 designated partners on record. No former designated partners are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sanjay Mukutlal Gupta Also directs: Impact Labs Private Limited | Designated Partner | 10 May 2012 | 14 Years 5 Months | Current |
| Rajendrakumar Makhanlal Gupta Also directs: Impact Labs Private Limited, Nikko Systems Private Limited | Designated Partner | 10 May 2012 | 14 Years 5 Months | Current |
| Pramesh Rajendrakumar Gupta | Designated Partner | 10 May 2012 | 14 Years 5 Months | Current |
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 09 May 2019 | 100264055 | Bombay Mercantile Co-Operative Bank Limited | ₹1 Cr | Open |
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Dove Pharma LLP are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Dove Pharma LLP; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Dove Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAIFD7037J1Z7 | Maharashtra | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Dove Pharma LLP, buy the company report.
Recent activity
Dove Pharma LLP has 3 designated partner changes on record since 2012: 3 appointments. The latest: Pramesh Rajendrakumar Gupta was appointed as Designated Partner on 10 May 2012.
Frequently asked questions
Dove Pharma is an active limited liability partnership based in Mumbai, Maharashtra, India. The LLP works in drug formulation and development, within the pharma industry. It was incorporated on 10 May 2012 (14+ years old) and is registered under LLPIN AAA-9155.
Dove Pharma has 3 current designated partners:
- Sanjay Mukutlal Gupta - Designated Partner
- Rajendrakumar Makhanlal Gupta - Designated Partner
- Pramesh Rajendrakumar Gupta - Designated Partner
The latest financial statements of Dove Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 31 March 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Dove Pharma is 27AAIFD7037J1Z7, registered in Maharashtra.
The LLPIN (Limited Liability Partnership Identification Number) of Dove Pharma is AAA-9155. It is issued by the Ministry of Corporate Affairs and uniquely identifies the LLP in India.
Dove Pharma was incorporated on 10 May 2012, making it 14+ years old. It is registered with the Registrar of Companies, Mumbai.
Pramesh Rajendrakumar Gupta was appointed as Designated Partner on 10 May 2012. Rajendrakumar Makhanlal Gupta was appointed as Designated Partner on 10 May 2012. Sanjay Mukutlal Gupta was appointed as Designated Partner on 10 May 2012.
The registered office of Dove Pharma is at 601 Lotus Business Park Premises Chs Ltd, Ram Baug Lane Off Sv Road Opp. Malad Dalmil Compound, Mumbai, Maharashtra, India – 400064.
Dove Pharma operates in the pharma industry, in the drug formulation and development segment.
Dove Pharma has open charges of ₹1 Cr and no satisfied charges on record as per latest MCA filings.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
